Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Aclaris Therapeutics Inc. (ACRS)

8.81 0.13 (1.5%)

11-16 16:00

Open:

8.6

Pre. Close:

8.68

High:

8.88

Low:

8.48

Volume:

610,540

Market Cap:

361M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.901 - 8.96

8.96 - 9.013

Low:

8.337 - 8.411

8.411 - 8.477

Close:

8.694 - 8.812

8.812 - 8.92

Technical analysis  (as of: 2018-11-16 4:30:32 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 13.63     One year: 15.94

Support:

Support1: 8.48    Support2: 7.06

Resistance:

Resistance1: 11.67    Resistance2: 13.65

Pivot:

10.98

Moving Averages:

MA(5): 9.22     MA(20): 11.27

MA(100): 15.46     MA(250): 18.46

MACD:

MACD(12,26): -1.13     Signal(12,26,9): -0.88

%K %D:

%K(14,3): 3.98     %D(3): 2.61

RSI:

RSI(14): 21.69

52-Week:

High: 26.25  Low: 8.48  Change(%): -61.4

Average Vol(K):

3-Month: 39290  10-Days 41215

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ACRS has closed above bottom band by 9.1%. Bollinger Bands are 100.6% wider than normal. The large width of the bands suggest high volatility as compared to ACRS's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

2018-11-11T03:13:04-05:00
Aclaris Therapeutics (ACRS) CEO Neal Walker on Q3 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

40.94

Shares Float (M)

39.20

% Held by Insiders

5.60

% Held by Institutions

69.50

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-3.850

EPS Est. Current Year

-3.100

EPS Est. Next Year

-3.170

EPS Est. Next Quarter

-1.130

Forward EPS

-3.209

Book Value (p.s.)

3.250

PEG Ratio

-0.04

Profit Margin

Operating Margin

-1623.56

Return on Assets (ttm)

-53.5

Return on Equity (ttm)

-60.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-75.63

Levered Free Cash Flow (M)

-38.19

Valuation

P/E

-2.29

P/E Growth Ratio

0.01

P/BV

2.71

P/S

1662572928.00

P/CF

-4.77

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.